These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5473023)

  • 21. Hypokalemia-induced ultrastructural, histochemical and connexin-43 alterations resulting in atrial and ventricular fibrillations.
    Tribulová N; Manoach M; Varon D; Okruhlicová L; Slobodová Z; Kubovcáková L
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():15-8. PubMed ID: 10707826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chamber-specific effects of hypokalaemia on ventricular arrhythmogenicity in isolated, perfused guinea-pig heart.
    Osadchii OE; Bentzen BH; Olesen SP
    Exp Physiol; 2009 Apr; 94(4):434-46. PubMed ID: 19151074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arrhythmia in hypokalemia.
    Daniell HW
    N Engl J Med; 1971 Jun; 284(24):1385. PubMed ID: 5576466
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypokalemia-induced ventricular fibrillation.
    Bektas F; Soyuncu S
    J Emerg Med; 2012 Feb; 42(2):184-5. PubMed ID: 20850253
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study.
    Higham PD; Adams PC; Murray A; Campbell RW
    Q J Med; 1993 Sep; 86(9):609-17. PubMed ID: 8255976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias.
    Nolan PE
    Pharmacotherapy; 1997; 17(2 Pt 2):65S-75S; discussion 89S-91S. PubMed ID: 9085342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; Pickron J; Goldman AM
    Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory alkalosis, hypokalemia, and repeated ventricular fibrillation associated with mechanical ventilation.
    Wright BD; DiGiovanni AJ
    Anesth Analg; 1969; 48(3):467-73. PubMed ID: 5815110
    [No Abstract]   [Full Text] [Related]  

  • 29. The efficacy of lidocaine in ventricular fibrillation due to coronary artery ligation: endotracheal vs intravenous use.
    Brown LK; Diamond J
    Proc West Pharmacol Soc; 1982; 25():43-5. PubMed ID: 7122535
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-K+ dependent QT prolongation and risk for ventricular arrhythmia in anorexia nervosa.
    Facchini M; Sala L; Malfatto G; Bragato R; Redaelli G; Invitti C
    Int J Cardiol; 2006 Jan; 106(2):170-6. PubMed ID: 16321688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
    Rea RS; Kane-Gill SL; Rudis MI; Seybert AL; Oyen LJ; Ou NN; Stauss JL; Kirisci L; Idrees U; Henderson SO
    Crit Care Med; 2006 Jun; 34(6):1617-23. PubMed ID: 16614583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine prophylactic lidocaine in acute myocardial infarction.
    Barnaby PF; Barrett PA; Lvoff R
    Heart Lung; 1983 Jul; 12(4):362-6. PubMed ID: 6553038
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of potassium salts and of electric shock in the correction of subentrant episodes of ventricular fibrillation in the course of quinidine therapy].
    Savastano A; Rocca F
    Minerva Med; 1969 Jan; 60(6):181-8. PubMed ID: 5776767
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
    Amino M; Yoshioka K; Iwata O; Fujikura H; Deguchi Y; Ban K; Shiina Y; Goto S; Handa S; Tanabe T; Nakagawa Y; Morita S; Iwase H; Yamamoto I; Inokuchi S; Marutani Y
    J Cardiol; 2003 Mar; 41(3):127-34. PubMed ID: 12674997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of thioridazine on electrical and ischemic ventricular fibrillation in the dog heart in situ.
    Davis JC; Bigger JT
    J Pharmacol Exp Ther; 1981 Jan; 216(1):39-44. PubMed ID: 7452506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism.
    Abdo A; Bebb RA; Wilkins GE
    Can J Cardiol; 1999 Mar; 15(3):347-8. PubMed ID: 10202199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pericardial lidocaine on hemodynamic parameters and responses in dogs anesthetized with midazolam and fentanyl.
    Takada M; Dohi S; Akamatsu S; Suzuki A
    J Cardiothorac Vasc Anesth; 2007 Jun; 21(3):393-9. PubMed ID: 17544893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aclarubicin-associated QTc prolongation and ventricular fibrillation.
    Iwata N; Karasawa M; Omine M; Maekawa T; Suzuki T; Kawai Y
    Cancer Treat Rep; 1984 Mar; 68(3):527-9. PubMed ID: 6584207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of asystolic reperfusion and reperfusate electrolyte composition influence postcardioplegia ventricular fibrillation.
    Holman WL; Spruell RD; Pacifico AD
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):511-9. PubMed ID: 8361195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Action of magnesium on ventricular fibrillation].
    Oliveira LH; Garcia EA
    Arq Bras Cardiol; 1984 May; 42(5):339-43. PubMed ID: 6508591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.